Several of the largest U.S. and European-based pharmaceutical companies entered into agreements with President Donald Trump on Friday to voluntarily reduce the prices of their medications, as his administration advocates for aligning domestic drug prices with lower prices available internationally. That includes Merck, Bristol Myers Squibb, Amgen, Gilead, GSK, Sanofi, Roche’s Genentech, privately-held Boehringer Ingelheim, Read More